RENO, Nev., April 7, 2011 /PRNewswire/ -- Visual Healthcare
Corp. (the "Company") (NASDAQ OTC: VSHC) announces that its new Lab
Automation module is quickly gaining traction with private sector
industrial clients. The Company has entered into a preliminary
agreement to implement a fully automated quality monitoring suite
in the laboratory of a leading bottled water brand in the New York
Tri State area. The initial deal is expected to be worth some
$1.8 – $2.2
million in the next two years.
The Visual Healthcare Laboratory Automation Platform, originally
designed for lab operations and results reporting within a
healthcare setting, has been re-engineered as a powerful
cross-disciplinary lab automation and quality control system that
provides true Quality Assurance.
This reliable advanced laboratory solution could prove critical
to those companies whose businesses are now required to move up
quality control functions to a much higher level of genuine
measurable quality assurance. There is a growing need to run
products through more stringent quality control processes, in this
case ensuring that millions of bottles of an added value natural
water product meet the standards of quality expected by paying
consumers.
"The quality of drinking water in the U.S. has come under
scrutiny in recent years and we can help the better producers
demonstrate the superior quality of their product scientifically,"
says Chairman Gerard Dab. "We look
at the water industry as a key sector in our diversification
strategy. This line should enable the company to generate healthy
cash flow considering our sunken cost base," concludes Mr. Dab.
This unexpectedly rapid breakthrough into consumer product
quality assurance is seen as a validation of a yearlong move to
redeploy our technology assets into new industries both in the core
U.S. and overseas markets.
ABOUT VISUAL HEALTHCARE
Visual Healthcare Corp., since 1998, designs, creates and
develops innovative information platforms, specifically conceived
for the automation of a wide range of scientific disciplines. These
include pharmaceutical research, clinical trials, laboratory
automation, true quality assurance tools, total quality control
applications, and quantitative analytic tools such as proprietary
frameworks for electronic health records, electronic prescription,
infection and disease control, and smart cancer registries. The
company's extensive portfolio of proprietary technologies is the
result of a unique collaboration between senior clinicians from the
McGill University Faculty of Medicine
and affiliated tertiary care centers, medical software architects,
and a Fortune 100 healthcare service company, investing some
$50 million in the process. The
Company licenses its technology to operating companies in exchange
for an equity stake or a royalty stream. It owns significant stakes
in various companies including VisualMED Clinical Solutions Corp.
(NASDAQ OTC: VMCS), a leader in the field of electronic health
records.
For more information, please visit:
www.visualhealthcarecorp.com.
FORWARD-LOOKING STATEMENTS
Except for historical information provided herein, this press
release may contain information and statements of a forward-looking
nature concerning the future performance of the Company. These
statements are based on suppositions and uncertainties as well as
on management's best possible evaluation of future events. Such
factors may include, without excluding other considerations,
fluctuations in quarterly results, evolution in customer demand for
the Company's products and services, the impact of price pressures
exerted by competitors, and general market trends or economic
changes. As a result, readers are advised that actual results may
differ from expected results.
SOURCE Visual Healthcare Corp.